Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 425.55
+5.55 (1.32%)
Aug 17, 2026, 4:19 PM GMT
Tristel Market Cap
Tristel has a market cap or net worth of 201.54 million as of August 17, 2026. Its market cap has increased by 17.34% in one year.
Market Cap
201.54M
Enterprise Value
194.08M
Revenue
49.54M
Ranking
n/a
PE Ratio
25.86
Stock Price
425.55
ChartMarket Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 201.54M, an increase of 2,817.94%. That is a compound annual growth rate of 17.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 201.54M | 1.06% |
| Dec 31, 2025 | 199.42M | -1.61% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| Allergy Therapeutics | 332.46M |
| Avacta Group | 299.78M |
| PureTech Health | 289.18M |
| NIOX Group | 284.51M |